Use of anti-mu monoclonal antibody as a therapeutic approach to achieve depletion of xenoreactive natural antibodies
Soares, M.; Nisol, F.; Bach, F.H.; Bazin, H.; Latinne, D.
Transplantation Proceedings 26(3): 1357-1359
1994
ISSN/ISBN: 0041-1345 PMID: 8029939 Document Number: 426123
Document emailed within 1 workday
Related Documents
Neipp, M.; Gammie, J.S.; Exner, B.G.; Li, S.; Chambers, W.H.; Pham, S.M.; Ildstad, S.T. 1999: A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment Transplantation 68(3): 369-378Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Agius, M.A.; Geannopoulos, C.J.; Fairclough, R.H.; Richman, D.P. 1988: Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding Journal of Immunology 140(1): 62-68
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Soiffer, R.J.; Ritz, J. 1993: Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results Bone Marrow Transplantation 12(Suppl 3): S7-10
Cramer, D.V.; Wu, G.D.; Borie, D.C.; Shirwan, H.; Miller, L.; Makowka, L. 1996: Germline VH gene usage in xenoreactive monoclonal antibody Transplantation Proceedings 28(2): 541-542
Parker, W.; Bruno, D.; Holzknecht, Z.E.; Platt, J.L. 1994: Characterization and affinity isolation of xenoreactive human natural antibodies Journal of Immunology 153(8): 3791-3803
Juhl, H.; Sievers, M.; Baltzer, K.; Helmig, F.; Wolf, H.; Brenner, W.; Kalthoff, H. 1995: A monoclonal antibody-cobra venom factor conjugate increases the tumor-specific uptake of a 99mTc-labeled anti-carcinoembryonic antigen antibody by a two-step approach Cancer Research 55(23 Suppl): 5749s-5755s
Müller-Werdan, U.; Klein, D.; Zander, M.; Werdan, K.; Hammer, C. 1994: Beating neonatal rat cardiomyocytes as a model to study the role of xenoreactive natural antibodies in xenotransplantation Transplantation 58(12): 1403-1409
Pruitt, S.K.; Weinstock, D.; Suyemoto, M.M.; Sanfilippo, F.; Baldwin, W.M. 1993: Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken Transplantation Proceedings 25(1 Pt 1): 435-437
Sawada, T.; Chung, Y.S.; Sowa, M. 1996: New therapeutic approach to pancreatic cancer by monoclonal antibodies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1654-1656
Feng, J.; Lü, J.; Qian, H. 1996: Serological analysis of antibodies by anti-idiotypic monoclonal antibody 6B11 against ovarian carcinoma Zhonghua Fu Chan Ke Za Zhi 31(8): 493-495
Chatenoud, L. 1988: Therapeutic use of the OKT3 anti-T cell monoclonal antibody: mode of action and side effects Transplantation Proceedings 20(5 Suppl 6: 79-83
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
McLigeyo, S.O.; Notghi, A.; Anderton, J.L.; Dick, J. 1990: Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody East African Medical Journal 67(9): 667-673
Wang, Z-hui.; Liao, Y-hua.; Yuan, J.; Zhang, L.; Wang, M.; Zhang, J-hui.; Liu, Z-ping.; Dong, J-hua. 2007: A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy Chinese Medical Journal 120(15): 1319-1325
Wagener, C.; Yang, Y.H.; Crawford, F.G.; Shively, J.E. 1983: Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies Journal of Immunology 130(5): 2308-2315
Ng, A.K.; Indiveri, F.; Pellegrino, M.A.; Molinaro, G.A.; Quaranta, V.; Ferrone, S. 1980: Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies Journal of Immunology 124(5): 2336-2340
Yu, P.B.; Holzknecht, Z.E.; Bruno, D.; Parker, W.; Platt, J.L. 1996: Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies Journal of Immunology 157(11): 5163-5168
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839